MedPath

Faes Farma S.A.

🇨🇱Chile
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

26

Active:24
Completed:0

Trial Phases

2 Phases

Phase 1:15
Phase 3:1

Drug Approvals

99

CIMA_AEMPS:99

Drug Approvals

ETOSUXIMIDA FAES 250 mg CAPSULAS DURAS

Approval Date
Jul 14, 2025
CIMA_AEMPS

CLAVERSAL ESPUMA RECTAL

Approval Date
Jul 14, 2025
CIMA_AEMPS

CLAVERSAL 500 mg COMPRIMIDOS GASTRORRESISTENTES

Approval Date
Jul 14, 2025
CIMA_AEMPS

VENOSMIL 20 mg/g GEL

Approval Date
Jul 14, 2025
CIMA_AEMPS

SEDOTIME 15 mg CAPSULAS DURAS

Approval Date
Jul 14, 2025
CIMA_AEMPS

ALERGICAL 0,5 mg/ 0,1mg/g CREMA

Approval Date
Jul 14, 2025
CIMA_AEMPS

SEDOTIME 45 mg CAPSULAS DURAS

Approval Date
Jul 14, 2025
CIMA_AEMPS

CLAVERSAL 500 mg SUPOSITORIOS

Approval Date
Jul 14, 2025
CIMA_AEMPS

AZZAVIX 1000 MG COMPRIMIDOS GASTRORRESISTENTES

Approval Date
Jul 14, 2025
CIMA_AEMPS

CLAVERSAL 1 G COMPRIMIDOS GASTRORRESISTENTES

Approval Date
Jul 14, 2025
CIMA_AEMPS
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 10
  • Next

Clinical Trials

Distribution across different clinical trial phases (16 trials with phase data)• Click on a phase to view related trials

Phase 1
15 (93.8%)
Phase 3
1 (6.3%)
No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.